According to a newspaper report, Novartis has confirmed that it will retain its respiratory disease research center in Horsham, UK, with 440 employees. The company will sell a portion of the site and plans to invest approximately £5 million to renovate some of the remaining buildings.
In March 2011, Novartis announced significant personnel reductions at the site but stated that respiratory research would stay; however, local officials were apparently concerned that the research center was still in danger.
Manufacturing at the site is scheduled to end in 2013.
Read the West Sussex County Times article.
